Menu
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 9
Original Research
Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,174 | Dovepress* | 6,318+ | 410 | 6,728 | |
| PubMed Central* | 856 | 413 | 1,269 | ||
| Totals | 7,174 | 823 | 7,997 | ||
| *Since 10 March 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar